Processa Pharmaceuticals files initial beneficial ownership statement for COO Gregory J. Flesher
PCSA•Processa Pharmaceuticals COO Gregory J. Flesher filed an initial statement of beneficial ownership dated Nov. 16, 2026.
PCSA•Processa Pharmaceuticals COO Gregory J. Flesher filed an initial statement of beneficial ownership dated Nov. 16, 2026.
Processa Pharmaceuticals Chief Operating Officer Gregory J. Flesher filed an initial statement of beneficial ownership dated Nov. 16, 2026.